Cargando…

Low Turnover Bone Disease in Early CKD Stages

Detalles Bibliográficos
Autores principales:	Barreto, Fellype Carvalho, Massy, Ziad A., Drueke, Tilman B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171700/ https://www.ncbi.nlm.nih.gov/pubmed/35685312 http://dx.doi.org/10.1016/j.ekir.2022.03.037

Ejemplares similares

Strategies for Phosphate Control in Patients With CKD
por: Barreto, Fellype Carvalho, et al.
Publicado: (2019)

Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022)

The Authors Reply
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival
por: Massy, Ziad A., et al.
Publicado: (2012)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD
por: Engberink, Agnes Oude, et al.
Publicado: (2022)

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Letter to the Editor: “Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors”
por: Vaisbich, Maria Helena, et al.
Publicado: (2020)

The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study
por: Hernandes, Fabiana Rodrigues, et al.
Publicado: (2017)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
por: Barreto, Fellype C., et al.
Publicado: (2017)

Bone biopsy in chronic kidney disease: still an option?
por: Drueke, Tilman B.
Publicado: (2020)

Update of Brazilian Guidelines for Treatment and Assessment of Chronic Kidney Disease – Mineral and Bone Disorders
por: Carvalho, Aluízio Barbosa, et al.
Publicado: (2021)

Bone Turnover in Azerbaijani Patients with Type 2 Diabetes
por: SAFAROVA, Sain Sattar
Publicado: (2020)

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
por: Kaboré, Jean, et al.
Publicado: (2016)

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD
por: El-Husseini, Amr, et al.
Publicado: (2022)

Plasma Oxalate Concentration and Patients With CKD
por: Oka, Yoshinari, et al.
Publicado: (2021)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

The non-steady state CKD-EPI calculator
por: Buchkremer, Florian, et al.
Publicado: (2021)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Prescription of Direct Oral Anticoagulants to Patients With Moderate-to-Advanced CKD: Too Little or Just Right?
por: Liabeuf, Sophie, et al.
Publicado: (2021)

Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
por: Six, Isabelle, et al.
Publicado: (2014)

Association Between Dietary Potassium Intake and Serum Potassium in CKD
por: Brown, Robert S.
Publicado: (2023)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

Differences in glomerular filtration rate estimated with the new eGFRcr CKD EPI age and sex 2021 vs. the eGFRcr CKD EPI 2009 formula
por: Campillo, Cristian Ríos, et al.
Publicado: (2022)

Effects of Low-Protein, and Supplemented Very Low–Protein Diets, on Muscle Protein Turnover in Patients With CKD
por: Garibotto, Giacomo, et al.
Publicado: (2018)

Thrombotic Microangiopathy: An Under-Recognized Cause of CKD Following Viper Envenomation
por: Arora, Sahil, et al.
Publicado: (2022)

Response to “Association Between Dietary Potassium Intake and Serum Potassium in CKD”
por: Ogata, Soshiro, et al.
Publicado: (2023)

Bone turnover markers in the early stage of rapidly progressive osteoarthritis of the hip
por: Yasuda, Tadashi, et al.
Publicado: (2021)

Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function
por: Cheddani, Lynda, et al.
Publicado: (2020)

The impact of type 2 diabetes on bone metabolism
por: Sanches, Claudia Pinheiro, et al.
Publicado: (2017)

Starting with low dose sulfonylurea and metformin in early stage type 2 diabetes mellitus
por: George, Joe
Publicado: (2015)

Comments on “Supervised Exercise Intervention and Overall Activity in CKD” by Pike et al.
por: Andrade, Francini Porcher, et al.
Publicado: (2020)

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
por: Yau, Kevin, et al.
Publicado: (2022)

Determination and Modulation of Total and Surface Calcium-Sensing Receptor Expression in Monocytes In Vivo and In Vitro
por: Paccou, Julien, et al.
Publicado: (2013)

Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
por: Favretto, Giane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mqekdli7dr3l9fauo0s7g6q043